If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Hattinger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Osteosarcoma Medicine & Life Sciences
Ewing's Sarcoma Medicine & Life Sciences
Genes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Comparative Genomic Hybridization Medicine & Life Sciences
Methotrexate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

An update on emerging drugs in osteosarcoma: towards tailored therapies?

Hattinger, C. M., Patrizio, M. P., Magagnoli, F., Luppi, S. & Serra, M., Sep 2019, In : Expert Opinion on Emerging Drugs. 24, 3, p. 153-171 19 p.

Research output: Contribution to journalArticle

Osteosarcoma
Pharmaceutical Preparations
Clinical Trials
Therapeutics
Neoplasms

Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment

Hattinger, C. M., Patrizio, M. P., Luppi, S., Magagnoli, F., Picci, P. & Serra, M., Apr 1 2019, In : Expert opinion on drug metabolism & toxicology. 15, 4, p. 299-311 13 p.

Research output: Contribution to journalArticle

Pharmacogenetics
Osteosarcoma
DNA
Polymorphism
Pharmaceutical Preparations

Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts

Gazzano, E., Buondonno, I., Marengo, A., Rolando, B., Chegaev, K., Kopecka, J., Saponara, S., Sorge, M., Hattinger, C. M., Gasco, A., Fruttero, R., Brancaccio, M., Serra, M., Stella, B., Fattal, E., Arpicco, S. & Riganti, C., Aug 2019, In : Cancer Letters. 456, p. 29-39 11 p.

Research output: Contribution to journalArticle

P-Glycoprotein
Osteosarcoma
Hyaluronic Acid
Heterografts
Liposomes

Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma

Buondonno, I., Gazzano, E., Tavanti, E., Chegaev, K., Kopecka, J., Fanelli, M., Rolando, B., Fruttero, R., Gasco, A., Hattinger, C., Serra, M. & Riganti, C., Nov 14 2018, In : Cellular and Molecular Life Sciences. 76, 3, p. 609-625 17 p.

Research output: Contribution to journalArticle

Osteosarcoma
Endoplasmic Reticulum
Doxorubicin
P-Glycoprotein
Endoplasmic Reticulum Stress

Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?

Hattinger, C. M., Patrizio, M. P., Tavanti, E., Luppi, S., Magagnoli, F., Picci, P. & Serra, M., Nov 2018, In : Expert Review of Molecular Diagnostics. 18, 11, p. 947-961 15 p.

Research output: Contribution to journalReview article

Genetic Testing
Osteosarcoma
Patient Selection
Biomarkers
Technology